Search

Your search keyword '"Kazanji, Mirdad"' showing total 9 results
Start Over Author "Kazanji, Mirdad" Database Gale General OneFile
9 results on '"Kazanji, Mirdad"'

1. Concurrent Clade I and Clade II Monkeypox Virus Circulation, Cameroon, 1979-2022

Author

Djuicy, Delia D., Sadeuh-Mba, Serge A., Bilounga, Chanceline N., Yonga, Martial G., Tchatchueng-Mbougua, Jules B., Essima, Gael D., Esso, Linda, Nguidjol, Ines M.E., Metomb, Steve F., Chebo, Cornelius, Agwe, Samuel M., Ankone, Placide A., Ngonla, Firmin N.N., Mossi, Hans M., Etoundi, Alain G.M., Eyangoh, Sara I., Kazanji, Mirdad, and Njouom, Richard

Subjects
Human monkeypox -- Causes of, DNA viruses -- Identification and classification -- Genetic aspects -- Distribution, Company distribution practices, Health
Abstract

Monkeypox virus (MPXV) is an emerging zoonotic Orthopoxvirus causing mpox in humans, a disease similar to the eradicated smallpox (1). Since identification in a monkey in 1958 (2) and a [...]

Published
2024
Full Text
View/download PDF

2. Specificity of dengue NS1 antigen in differential diagnosis of dengue and Zika virus infection

Author

Matheus, Severine, Boukhari, Rachida, Labeau, Bhety, Ernault, Valerie, Bremand, Laetitia, Kazanji, Mirdad, and Rousset, Dominique

Subjects
Health
Abstract

To the Editor: Circulation of new arboviruses of the genus Flavivirus poses a major problem for differential diagnosis. Zika virus, a mosquitoborne virus of the family Flaviviridae, is closely related [...]

Published
2016

3. Timeliness of yellow fever surveillance, Central African Republic

Author

Rachas, Antoine, Nakoune, Emmanuel, Bouscaillou, Julie, Paireau, Juliette, Selekon, Benjamin, Senekian, Dominique, Fontanet, Arnaud, and Kazanji, Mirdad

Subjects
Epidemics -- Control -- Central African Republic, Vaccination -- Usage, Yellow fever -- Risk factors -- Diagnosis -- Care and treatment, Diseases -- Relapse, Sentinel health events -- Usage, Enzyme-linked immunosorbent assay -- Usage, Health, World Health Organization -- Standards
Abstract

Because the number of reported cases of yellow fever has increased over the past 2 decades, it is considered a reemerging disease (1,2). The World Health Organization (WHO) requires that [...]

Published
2014
Full Text
View/download PDF

4. Early introduction and delayed dissemination of pandemic influenza, Gabon

Author

Lekana-Douki, Sonia Etenna, Mouinga-Ondeme, Augustin, Nkoghe, Dieudonne, Drosten, Christian, Drexler, Jan Felix, Kazanji, Mirdad, and Leroy, Eric M.

Subjects
Epidemics -- Gabon -- Health aspects, Influenza -- Health aspects, Public health -- Health aspects, Health
Abstract

In April 2009, a pandemic strain of influenza A (H1N1) (pH1N1) virus emerged in Mexico and the United States; the World Health Organization declared a pandemic alert on June 11, [...]

Published
2013
Full Text
View/download PDF

5. Mayaro virus in wild mammals, French Guiana

Author

de Thoisy, Benoit, Gardon, Jacques, Alba Salas, Rosa, Morvan, Jacques, and Kazanji, Mirdad

Subjects
RNA viruses -- Research
Abstract

A serologic survey for Mayaro virus (Alphavirus, Togaviridae) in 28 wild nonflying forest mammal species in French Guiana showed a prevalence ranging from 0% to 52% and increasing with age. [...]

Published
2003

6. Imported hepatitis E virus, Central African Republic, 2011

Author

Bouscaillou, Julie, Komas, Narcisse, Tricou, Vianney, Nakoune, Emmanuel, Selekon, Benjamin, Fontanet, Arnaud, and Kazanji, Mirdad

Subjects
Hepatitis E virus -- Identification and classification -- Health aspects -- Genetic aspects -- Research, Disease transmission -- Health aspects -- Research, Polymerase chain reaction -- Usage, Health
Abstract

To the Editor: Hepatitis E virus (HEV) is endemic to India (1,2) and Central African Republic (3,4), although different strains circulate in the countries. In May 2011, a case of [...]

Published
2013

8. An HTLV-I/II vaccine: from animal models to clinical trials?

Author

De The, Guy and Kazanji, Mirdad

Subjects
Viral vaccines -- Research, HTLV-I infections -- Prevention, HTLV-II infections -- Prevention, Adult T-cell leukemia-lymphoma -- Prevention, Paraparesis, Tropical spastic -- Prevention, Health
Abstract

It is time to consider developing a vaccine against the human T-lymphotropic viruses, HTLV-I and HTLV-II. HTLV-I is widespread in Asia, parts of Africa and Central and South America. It causes adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). These diseases can be fatal and up to 10% of the 15 million to 25 million HTLV-infected people worldwide could develop them. HTLV-II has been linked to diseases similar to TSP/HAM. A vaccine against HTLV could be very beneficial because the viruses are so stable genetically.

Published
1996

9. Geographic variation in human herpesvirus 8 seroprevalence and possible association with exposure to bites from blood-sucking arthropods

Author

Ascoli, Valeria, Manno, Daniela, Coluzzi, Mario, Kazanji, Mirdad, Dussart, Philippe, Tortevoye, Patricia, Duprez, Renan, and Gessain, Antoine

Subjects
Human herpesvirus 8 -- Analysis, Herpes -- Demographic aspects, Herpes -- Research, Herpesvirus diseases -- Demographic aspects, Herpesvirus diseases -- Research, Prevalence studies (Epidemiology) -- Research, Arthropoda -- Research, Health
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results